MOH grants conditional approval of Veklury for COVID-19 treatment
The MOH has granted conditional registration approval for Veklury (remdesivir) for the emergency treatment of COVID-19.
Thu Jul 07 2022
FDA AS lulus rawatan COVID-19 pertama bagi kanak-kanak
Langkah itu menyaksikan Veklury, rawatan COVID-19 pertama diluluskan untuk kanak-kanak berumur kurang daripada 12 tahun.
Tue Apr 26 2022
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Results of the overall study suggested the drug may reduce mortality, but the benefit was not statistically significant.
Fri Oct 09 2020